BioXcel Therapeutics (BTAI) Change in Inventory (2022 - 2026)

BioXcel Therapeutics' Change in Inventory history runs 5 years deep, the most recent figure standing at -$222000.0 for Q1 2026.

• In Q1 2026, Change in Inventory fell 500.0% year-over-year to -$222000.0; the TTM figure through Mar 2026 stood at -$142000.0 (up 92.1% YoY), while the FY2025 annual figure was $43000.0, up 103.28% from the prior year.
• Change in Inventory was -$222000.0 for Q1 2026 at BioXcel Therapeutics, down from $263000.0 in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $713000.0 in Q2 2022 to a low of -$1.2 million in Q3 2024.
• Historically, Change in Inventory has averaged $29411.8 across 5 years, with a median of -$27000.0 in 2023.
• Biggest YoY gain for Change in Inventory was 1457.58% in 2024; the steepest drop was 3033.33% in 2024.
• A 5-year view of Change in Inventory shows it stood at $577000.0 in 2022, then sank by 104.68% to -$27000.0 in 2023, then plunged by 3033.33% to -$846000.0 in 2024, then soared by 131.09% to $263000.0 in 2025, then sank by 184.41% to -$222000.0 in 2026.
• The last three Change in Inventory figures came in at -$222000.0 (Q1 2026), $263000.0 (Q4 2025), and -$47000.0 (Q3 2025), per Business Quant data.